Novartis AG EBIT Margin for the year ending December 31, 2024: 28.32%

Novartis AG EBIT Margin is 28.32% for the year ending December 31, 2024, a 32.42% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Novartis AG EBIT Margin for the year ending December 31, 2023 was 21.38%, a 16.51% change year over year.
  • Novartis AG EBIT Margin for the year ending December 31, 2022 was 18.35%, a -68.12% change year over year.
  • Novartis AG EBIT Margin for the year ending December 31, 2021 was 57.57%, a 167.31% change year over year.
  • Novartis AG EBIT Margin for the year ending December 31, 2020 was 21.54%, a 7.09% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin